+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nuclear Radiation Therapeutic Drugs Market - Global Forecast 2025-2030- Product Image
Nuclear Radiation Therapeutic Drugs Market - Global Forecast 2025-2030- Product Image
Sale

Nuclear Radiation Therapeutic Drugs Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6138929
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The nuclear radiation therapeutics market is advancing rapidly as industry players leverage next-generation radioconjugates and precision medicine initiatives to redefine oncology paradigms. With evolving clinical adoption and regulatory clarity, stakeholders are positioned to capture growth, capitalize on emerging technologies, and optimize care outcomes.

Market Snapshot: Nuclear Radiation Therapeutics

The nuclear radiation therapeutics sector is experiencing robust expansion, driven by the convergence of targeted radioconjugate development, antibody engineering, and innovative diagnostic imaging. Companies are intensifying investment in product pipelines while adapting to streamlined regulatory frameworks and shifting supply chain strategies. Newly announced tariff measures are introducing cost pressures, prompting organizations to re-align sourcing methods, and regional market differences are affecting adoption pathways and research initiatives. This highly dynamic environment is fostering partnerships, expediting clinical translation, and unlocking new precision oncology options.

Scope & Segmentation

This report provides a detailed analysis of the nuclear radiation therapeutics market, mapping key drivers, segmentation trends, and emerging stakeholder strategies across the value chain.

  • Product Types: Radioconjugates (including antibody and small molecule conjugates), radioimmunotherapy (bifunctional antibodies, pretargeted therapy), and radiopharmaceuticals (peptide receptor ligand therapy, PSMA ligand therapy)
  • Therapeutic Applications: Bone metastases, neuroendocrine tumors, prostate cancer, and thyroid cancer
  • End Users: Cancer treatment centers, hospitals, research institutes
  • Radionuclide Types: Alpha emitters and beta emitters, each with distinct tissue penetration and cytotoxicity profiles
  • Administration Routes: Intravenous and oral dosing approaches
  • Distribution Channels: Direct sales and third-party logistics partners
  • Regional Coverage: Americas (with in-depth focus on major U.S. states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including U.K., Germany, France, and multiple others), and Asia-Pacific (with specific attention to China, Japan, India, and regional manufacturing initiatives)
  • Competitive Landscape: Profiles key players such as Novartis AG, Bayer AG, Curium Pharma SA, Lantheus Holdings, Inc, Telix Pharmaceuticals Limited, Actinium Pharmaceuticals, Fusion Pharmaceuticals, RayzeBio, RadioMedix, and Eckert & Ziegler AG

Key Takeaways: Strategic Insights for Decision-Makers

  • Nuclear radiation therapeutics combine precise cytotoxicity with real-time imaging, allowing tailored regimens and reduced toxicity compared to traditional options.
  • Emerging radiochemistry and ligand design are creating assets with higher tumor specificity and enhanced pharmacokinetics, expanding application scope across cancer indications.
  • Clinical workflows now integrate artificial intelligence to refine treatment plans, optimize dosing, and enhance patient selection based on molecular profiles.
  • Adaptive regulatory pathways and agency guidance are lowering barriers to market entry, shortening timelines from preclinical to approval stages.
  • Collaborative development—spanning biotechnology, diagnostics, and contract research—supports innovation and enables smaller enterprises to drive platform advancement.
  • Regional capability-building and vertical integration are becoming crucial for reliable isotope supply and consistent therapeutic delivery.

Tariff Impact: 2025 U.S. Trade Policy Implications

Tariff measures scheduled in the United States for 2025 are set to affect the nuclear radiation therapeutic supply chain by increasing costs for enriched isotopes and other specialized inputs. Larger facility operators with on-site cyclotron infrastructure may absorb these impacts more effectively, while smaller contract manufacturers may face tightened margins. As a result, near-shoring, regional partnerships, and domestic isotope sourcing are being pursued to reduce exposure to cost volatility. Elevated input costs may influence clinical supply availability, hospital procurement, and patient access, emphasizing the need for long-term supply agreements and proactive risk management.

Methodology & Data Sources

This report is grounded in rigorous, multi-stage research methods, combining in-depth interviews with industry leaders, insights from clinical case studies, and analysis of peer-reviewed publications, patent records, and regulatory documents. Quantitative trend extrapolation ensures robust, unbiased data interpretation to support reliable market intelligence.

Why This Report Matters

  • Enables strategic planning by revealing high-impact product and application segments and anticipating regulatory shifts
  • Supports operational risk mitigation and sourcing strategies amid evolving trade policies and supply chain disruptions
  • Provides actionable intelligence for aligning R&D investment, partnerships, and go-to-market initiatives in targeted regions

Conclusion

Senior decision-makers will gain clear insights into the evolving nuclear radiation therapeutics landscape, enabling fact-based resource allocation and rapid response to industry shifts. This report offers a vital foundation for strategic action in precision oncology innovation.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of targeted alpha-emitter therapies such as Actinium-225 radiopharmaceuticals
5.2. Rapid growth of PSMA-targeted radioligand therapy adoption in prostate cancer treatment
5.3. Integration of radiopharmaceuticals with immunotherapy protocols to enhance antitumor response
5.4. Acceleration of regulatory approval pathways for novel radionuclide therapeutic agents by FDA and EMA
5.5. Emergence of theranostic platforms combining PET imaging with targeted radionuclide treatment modalities
5.6. Investment surge in cyclotron and isotope production infrastructure to ensure radionuclide supply chain resilience
5.7. Development of novel radionuclides such as terbium-161 and copper-64 for personalized theranostic applications
5.8. Advancements in personalized dosimetry and AI-driven treatment planning to optimize therapeutic efficacy and safety
5.9. Strategic collaborations between biotech firms and large pharmaceutical companies to accelerate radiopharmaceutical commercialization
5.10. Evolution of reimbursement frameworks and payer guidelines impacting market access for nuclear radiation therapeutics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Nuclear Radiation Therapeutic Drugs Market, by Product Type
8.1. Introduction
8.2. Radioconjugate
8.2.1. Antibody Conjugate
8.2.2. Small Molecule Conjugate
8.3. Radioimmunotherapy
8.3.1. Bifunctional Antibody
8.3.2. Pretargeted Therapy
8.4. Radiopharmaceutical
8.4.1. Peptide Receptor Ligand Therapy
8.4.2. Psma Ligand Therapy
9. Nuclear Radiation Therapeutic Drugs Market, by Therapeutic Application
9.1. Introduction
9.2. Bone Metastases
9.3. Neuroendocrine Tumors
9.4. Prostate Cancer
9.5. Thyroid Cancer
10. Nuclear Radiation Therapeutic Drugs Market, by End User
10.1. Introduction
10.2. Cancer Treatment Centers
10.3. Hospitals
10.4. Research Institutes
11. Nuclear Radiation Therapeutic Drugs Market, by Radionuclide Type
11.1. Introduction
11.2. Alpha Emitter
11.3. Beta Emitter
12. Nuclear Radiation Therapeutic Drugs Market, by Administration Route
12.1. Introduction
12.2. Intravenous
12.3. Oral
13. Nuclear Radiation Therapeutic Drugs Market, by Distribution Channel
13.1. Introduction
13.2. Direct Sales
13.3. Third Party Logistics
14. Americas Nuclear Radiation Therapeutic Drugs Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Nuclear Radiation Therapeutic Drugs Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Nuclear Radiation Therapeutic Drugs Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Novartis AG
17.3.2. Bayer AG
17.3.3. Curium Pharma SA
17.3.4. Lantheus Holdings, Inc
17.3.5. Telix Pharmaceuticals Limited
17.3.6. Actinium Pharmaceuticals, Inc
17.3.7. Fusion Pharmaceuticals, Inc
17.3.8. RayzeBio, Inc
17.3.9. RadioMedix, Inc
17.3.10. Eckert & Ziegler AG
18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix
List of Figures
FIGURE 1. NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET: RESEARCHAI
FIGURE 28. NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 29. NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET: RESEARCHCONTACTS
FIGURE 30. NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ANTIBODY CONJUGATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ANTIBODY CONJUGATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE CONJUGATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY SMALL MOLECULE CONJUGATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY BIFUNCTIONAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY BIFUNCTIONAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRETARGETED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRETARGETED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PEPTIDE RECEPTOR LIGAND THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PEPTIDE RECEPTOR LIGAND THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PSMA LIGAND THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PSMA LIGAND THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY BONE METASTASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY BONE METASTASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THYROID CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THYROID CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY CANCER TREATMENT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY CANCER TREATMENT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ALPHA EMITTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ALPHA EMITTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY BETA EMITTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY BETA EMITTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THIRD PARTY LOGISTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THIRD PARTY LOGISTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 111. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2018-2024 (USD MILLION)
TABLE 114. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2025-2030 (USD MILLION)
TABLE 115. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 116. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 117. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 118. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 119. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2024 (USD MILLION)
TABLE 124. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2025-2030 (USD MILLION)
TABLE 125. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 126. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 127. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. CANADA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 134. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 135. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 136. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 137. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2024 (USD MILLION)
TABLE 142. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2025-2030 (USD MILLION)
TABLE 143. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. MEXICO NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2018-2024 (USD MILLION)
TABLE 224. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2025-2030 (USD MILLION)
TABLE 225. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 226. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 227. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 228. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 229. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2024 (USD MILLION)
TABLE 234. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2025-2030 (USD MILLION)
TABLE 235. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 236. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 237. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. GERMANY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2018-2024 (USD MILLION)
TABLE 242. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2025-2030 (USD MILLION)
TABLE 243. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 244. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 245. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 246. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 247. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2024 (USD MILLION)
TABLE 252. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2025-2030 (USD MILLION)
TABLE 253. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 254. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 255. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. FRANCE NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIONUCLIDE TYPE, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. ITALY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 276. ITALY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 277. ITALY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2018-2024 (USD MILLION)
TABLE 278. ITALY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOCONJUGATE, 2025-2030 (USD MILLION)
TABLE 279. ITALY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 280. ITALY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOIMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 281. ITALY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 282. ITALY NUCLEAR RADIATION THERAPEUTIC DRUGS MARKET SIZE, BY RADIOPHARMACEUTICAL, 2025-2030 (USD MILLI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Nuclear Radiation Therapeutic Drugs Market report include:
  • Novartis AG
  • Bayer AG
  • Curium Pharma SA
  • Lantheus Holdings, Inc
  • Telix Pharmaceuticals Limited
  • Actinium Pharmaceuticals, Inc
  • Fusion Pharmaceuticals, Inc
  • RayzeBio, Inc
  • RadioMedix, Inc
  • Eckert & Ziegler AG

Related Topics

Related Reports

Nuclear Radiopharmaceutical Market - Global Forecast 2025-2030 - Product Image

Nuclear Radiopharmaceutical Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Therapeutic Nuclear Drug Market Report 2025 - Product Image

Therapeutic Nuclear Drug Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Nuclear Grade Activated Carbon Market - Global Forecast 2025-2030 - Product Image

Nuclear Grade Activated Carbon Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Nuclear Protective Clothing - Global Strategic Business Report - Product Image

Nuclear Protective Clothing - Global Strategic Business Report

  • Report
  • 273 Pages
  • Global
From
Nuclear Radiation Scanner Global Market Report 2025 - Product Image

Nuclear Radiation Scanner Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.